The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
Abstract
Background Multiple Sclerosis is associated with low serum levels of 25-hydroxyvitamin D (25(OH)D). We investigated the association between serum levels of 25(OH)D and 1,25-dihydroxyvitamin D (1,25(OH)2D), the biologically active metabolite, and clinical MS severity as expressed by EDSS-score and relapse rate. Study-design Cross-sectional study. Patients and Methods Serum samples from 267 MS patients were collected for 25(OH)D and 1,25(OH)2D measurement. Clinical MS parameters at the date of serum sampling were determined. Results: Both metabolite levels were significantly lower in the progressive forms compared to the relapsing remitting (RR)MS phenotype. In RRMS patients (disease course ≤ 5 years), high 25(OH)D levels were associated with a high chance of remaining relapse-free. Low 25(OH)D levels were associated with high EDSS-scores. 1,25(OH)2D was not directly associated with relapse rate or EDSS-score, and was dependent of age and 25(OH)D level. Conclusion Serum levels of 25(OH)D were associated with both relapse rate and disability in MS patients. These results are suggestive for a disease modulating effect of the serum concentrations of 25(OH)D on MS. The low circulating 1,25(OH)2D levels in progressive MS are due to older age and lower 25(OH)D levels. The potential consequences for vitamin D supplementation in MS will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
Estimates of optimal vitamin D status
Dawson-Hughes, B., Heaney, R. P., Holick, M. F., Lips, P., Meunier, P. J., & Vieth, R. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1867-7 · Cited by 1,854
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.x5001-0 · Cited by 769
Cantorna, M. T., Hayes, C. E., & DeLuca, H. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7861 · Cited by 718
Lemire, J. M., & Archer, D. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115072 · Cited by 472
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
Mei, I. A. F., Ponsonby, A.-L., Dwyer, T., Blizzard, L., Taylor, B. V., Kilpatrick, T., Butzkueven, H., & McMichael, A. J. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0315-8 · Cited by 321
Vitamin D as an immune modulator in multiple sclerosis, a review
Smolders, J., Damoiseaux, J., Menheere, P., & Hupperts, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.014 · Cited by 317
Self-citationCytokine profile in patients with multiple sclerosis following vitamin D supplementation
Mahon, B. D., Gordon, S. A., Cruz, J., Cosman, F., & Cantorna, M. T. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00396-x · Cited by 299
Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice
Spach, K. M., & Hayes, C. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.4119 · Cited by 250
Cited by
Vitamin D and the immune system
Aranow, C. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31821b8755 · Cited by 1,436
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
Simpson, S., Taylor, B., Blizzard, L., Ponsonby, A., Pittas, F., Tremlett, H., Dwyer, T., Gies, P., & van der Mei, I. (2010) · Annals of Neurology · doi:10.1002/ana.22043 · Cited by 457
Vitamin D and Multiple Sclerosis: A Comprehensive Review
Sintzel, M. B., Rametta, M., & Reder, A. T. (2018) · Neurology and Therapy · doi:10.1007/s40120-017-0086-4 · Cited by 435
Vitamin D: An Evidence-Based Review
Kulie, T., Groff, A., Redmer, J., Hounshell, J., & Schrager, S. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.06.090037 · Cited by 347
Review: The role of vitamin D in nervous system health and disease
DeLuca, G. C., Kimball, S. M., Kolasinski, J., Ramagopalan, S. V., & Ebers, G. C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12020 · Cited by 326
Metadata
- Authors
- Smolders, J., Menheere, P., Kessels, A., Damoiseaux, J., & Hupperts, R.
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2008-07-24
- Volume
- 14
- Issue
- 9
- Pages
- 1220-1224
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2140560855
- Cited by
- 340
- References
- 16
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. https://app.cochat.ai/papers/10.1177/1352458508094399
- The paper
- Smolders, J., Menheere, P., Kessels, A., Damoiseaux, J., & Hupperts, R. (2008). Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458508094399
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.